...
search icon
npce-img

Neuropace Inc Share Price

NPCE
NMQ
$15.05
+$0.55
(3.79%)
1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Neuropace Inc Analyst Forecast

Neuropace Inc Share Price Chart

Neuropace Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$482.96M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
118.52K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.86
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$7.56 L
$18.98 H
$15.05

About Neuropace Inc, Common Stock

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Neuropace Inc Stock Returns

Time FrameNPCESectorS&P500
1-Week Return-3.96%-1.08%-1.38%
1-Month Return-6.7%-0.47%-1.81%
3-Month Return17.49%2.13%1.38%
6-Month Return61.48%17.04%5.68%
1-Year Return24.48%6.56%11.74%
3-Year Return235.94%16.78%65.15%
5-Year Return-39.7%34.34%73.68%

Neuropace Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue41.14M45.18M45.52M65.42M79.91M[{"date":"2020-12-31","value":51.48,"profit":true},{"date":"2021-12-31","value":56.55,"profit":true},{"date":"2022-12-31","value":56.97,"profit":true},{"date":"2023-12-31","value":81.87,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue10.87M11.75M13.03M17.30M20.82M[{"date":"2020-12-31","value":52.19,"profit":true},{"date":"2021-12-31","value":56.42,"profit":true},{"date":"2022-12-31","value":62.57,"profit":true},{"date":"2023-12-31","value":83.08,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit30.27M33.44M32.49M48.12M59.09M[{"date":"2020-12-31","value":51.23,"profit":true},{"date":"2021-12-31","value":56.59,"profit":true},{"date":"2022-12-31","value":54.99,"profit":true},{"date":"2023-12-31","value":81.45,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin73.59%74.00%71.38%73.56%73.94%[{"date":"2020-12-31","value":99.44,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.46,"profit":true},{"date":"2023-12-31","value":99.4,"profit":true},{"date":"2024-12-31","value":99.92,"profit":true}]
Operating Expenses43.32M57.17M73.29M75.30M80.76M[{"date":"2020-12-31","value":53.65,"profit":true},{"date":"2021-12-31","value":70.8,"profit":true},{"date":"2022-12-31","value":90.75,"profit":true},{"date":"2023-12-31","value":93.24,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(13.05M)(23.74M)(40.79M)(27.17M)(21.67M)[{"date":"2020-12-31","value":-1305100000,"profit":false},{"date":"2021-12-31","value":-2373700000,"profit":false},{"date":"2022-12-31","value":-4079400000,"profit":false},{"date":"2023-12-31","value":-2717400000,"profit":false},{"date":"2024-12-31","value":-2167100000,"profit":false}]
Total Non-Operating Income/Expense(22.67M)(19.30M)(12.24M)(11.25M)(11.24M)[{"date":"2020-12-31","value":-2267200000,"profit":false},{"date":"2021-12-31","value":-1930500000,"profit":false},{"date":"2022-12-31","value":-1223900000,"profit":false},{"date":"2023-12-31","value":-1124900000,"profit":false},{"date":"2024-12-31","value":-1124400000,"profit":false}]
Pre-Tax Income(24.28M)(36.08M)(47.08M)(32.96M)(27.14M)[{"date":"2020-12-31","value":-2427800000,"profit":false},{"date":"2021-12-31","value":-3608000000,"profit":false},{"date":"2022-12-31","value":-4708200000,"profit":false},{"date":"2023-12-31","value":-3295600000,"profit":false},{"date":"2024-12-31","value":-2714100000,"profit":false}]
Income Taxes11.70M2.03M6.29M1.44M-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":17.34,"profit":true},{"date":"2022-12-31","value":53.73,"profit":true},{"date":"2023-12-31","value":12.28,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(35.98M)(38.11M)(53.37M)(34.39M)-[{"date":"2020-12-31","value":-3598200000,"profit":false},{"date":"2021-12-31","value":-3810900000,"profit":false},{"date":"2022-12-31","value":-5337000000,"profit":false},{"date":"2023-12-31","value":-3439310500,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(24.28M)(36.08M)(47.08M)(32.96M)(27.14M)[{"date":"2020-12-31","value":-2427800000,"profit":false},{"date":"2021-12-31","value":-3608000000,"profit":false},{"date":"2022-12-31","value":-4708200000,"profit":false},{"date":"2023-12-31","value":-3295600000,"profit":false},{"date":"2024-12-31","value":-2714100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(24.28M)(36.08M)(47.08M)(32.96M)(27.14M)[{"date":"2020-12-31","value":-2427800000,"profit":false},{"date":"2021-12-31","value":-3608000000,"profit":false},{"date":"2022-12-31","value":-4708200000,"profit":false},{"date":"2023-12-31","value":-3295600000,"profit":false},{"date":"2024-12-31","value":-2714100000,"profit":false}]
EPS (Diluted)(0.17)(33.99)(1.92)(1.28)(0.95)[{"date":"2020-12-31","value":-17,"profit":false},{"date":"2021-12-31","value":-3399,"profit":false},{"date":"2022-12-31","value":-192,"profit":false},{"date":"2023-12-31","value":-128,"profit":false},{"date":"2024-12-31","value":-95,"profit":false}]

Neuropace Inc Ratios

Neuropace Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

NPCE
Cash Ratio 3.06
Current Ratio 4.86
Quick Ratio 3.94

Neuropace Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NPCE
ROA (LTM) -11.19%
ROE (LTM) -169.27%

Neuropace Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NPCE
Debt Ratio Lower is generally better. Negative is bad. 0.83
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.17

Neuropace Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NPCE
Trailing PE NM
Forward PE NM
P/S (TTM) 5.28
P/B 27.07
Price/FCF NM
EV/R 5.40
EV/Ebitda NM

FAQs

What is Neuropace Inc share price today?

Neuropace Inc (NPCE) share price today is $15.05

Can Indians buy Neuropace Inc shares?

Yes, Indians can buy shares of Neuropace Inc (NPCE) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NPCE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Neuropace Inc be purchased?

Yes, you can purchase fractional shares of Neuropace Inc (NPCE) via the Vested app. You can start investing in Neuropace Inc (NPCE) with a minimum investment of $1.

How to invest in Neuropace Inc shares from India?

You can invest in shares of Neuropace Inc (NPCE) via Vested in three simple steps:

  • Click on Sign Up or Invest in NPCE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Neuropace Inc shares
What is Neuropace Inc 52-week high and low stock price?

The 52-week high price of Neuropace Inc (NPCE) is $18.98. The 52-week low price of Neuropace Inc (NPCE) is $7.56.

What is Neuropace Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Neuropace Inc (NPCE) is

What is Neuropace Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Neuropace Inc (NPCE) is 27.07

What is Neuropace Inc dividend yield?

The dividend yield of Neuropace Inc (NPCE) is 0.00%

What is the Market Cap of Neuropace Inc?

The market capitalization of Neuropace Inc (NPCE) is $482.96M

What is Neuropace Inc's stock symbol?

The stock symbol (or ticker) of Neuropace Inc is NPCE

How Can Investors Use Neuropace Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Neuropace Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Neuropace Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Neuropace Inc shares for Indian investors?

When investing in Neuropace Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Neuropace Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Neuropace Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Neuropace Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Neuropace Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top